About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Impact of Hyperuricemia on Psoriatic Arthritis | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06125444

Impact of Hyperuricemia on Psoriatic Arthritis

Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link b...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Renaud FELTEN, MD

CONTACT

33 3 88 12 79 64 renaud.felten@chru-strasbourg.fr

Sponsors

Lead Sponsor

University Hospital, Strasbourg, France

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Major subject (≥18 years old)
•Subject with a history of psoriatic arthritis objectified according to the CIM 10-1 coding for patients followed in hospitalization at the HUS and HCC
•Subject presenting psoriatic arthritis objectified during a consultation by an HCC rheumatologist
•Among these two populations, all subjects for whom at least one serum uric acid assay was available in the medical file
•Subject having not expressed, after being informed, opposition to the reuse of their data for research purposes
•Subject under guardianship or curatorship
•Subject under safeguard of justice

Exclusion Criteria

•Subject who expressed their opposition to participating in the study

Related studies

RECRUITINGPhase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · Psoriatic Arthritis

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 2/3

A Study of Picankibart in Patients With Active Psoriatic Arthritis

NCT07295509 · Psoriatic Arthritis

RECRUITINGPhase 3

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

NCT07286058 · Psoriatic Arthritis

RECRUITINGPhase 3

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

NCT06100744 · Juvenile Psoriatic Arthritis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment242

Start dateAug 2020

Last updatedDec 8, 2023

Condition

Psoriatic Arthritis

Locations shown

Service de Rhumatologie - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions